Neuropace (NPCE) vs Orthofix Medical (OFIX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Neuropace (NPCE) has outperformed Orthofix Medical (OFIX) over the past year, gaining 19.8% versus a loss of 35.2%. Over five years, NPCE leads with a -18.6% price change compared with -74.6% for OFIX. Neuropace is the larger company by market cap ($425.6 million vs $360.0 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NPCE | OFIX |
|---|---|---|
| Share price | $12.40 | $8.91 |
| Market cap | $425.62M | $359.95M |
| 1-day change | -2.82% | -3.21% |
| YTD return | -17.36% | -39.31% |
| 1-year return | +19.81% | -35.21% |
| 5-year return | -18.57% | -74.61% |
| Forward P/E | — | 24.07 |
| EPS (TTM) | $-0.57 | $-1.52 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.60 | $16.99 |
| 52-week low | $9.22 | $8.50 |
| Distance from 52-week high | -36.73% | -47.59% |
| Analyst consensus | none | none |
| Avg. price target upside | +61.29% | +45.99% |
| Average volume | 169.86K | 364.58K |
| Shares outstanding | 34.32M | 40.42M |
| Employees | 220 | 1,605 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NPCE has outperformed OFIX by 55.0 percentage points over the past year.
About Neuropace
NPCE stock →NeuroPace, Inc. operates as a medical device company in the United States.
Health Care · Medical/Dental Instruments · 220 employees
About Orthofix Medical
OFIX stock →Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction.
Health Care · Medical/Dental Instruments · 1,605 employees
NPCE vs OFIX FAQ
Which is bigger, Neuropace or Orthofix Medical?
Neuropace (NPCE) is larger, with a market capitalization of $425.62M compared with $359.95M for Orthofix Medical (OFIX).
Which stock has performed better over the past year, NPCE or OFIX?
NPCE returned +19.81% over the past 12 months, compared with -35.21% for OFIX (price return, excluding dividends). Past performance does not predict future results.
Are Neuropace and Orthofix Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.